SGTX - Sigilon Therapeutics EPS misses by $0.59 beats on revenue March, 18 2021 04:37 PM Sigilon Therapeutics Inc. Sigilon Therapeutics (SGTX): Q4 GAAP EPS of -$1.15 misses by $0.59.Revenue of $3.76M (+21.7% Y/Y) beats by $0.56M.Press Release For further details see: Sigilon Therapeutics EPS misses by $0.59, beats on revenue